Results for “Disease”

The Guardian US Jessica Glenza

US could lose measles-free status soon as RFK Jr’s pushes anti-vaccine agenda

Country is in the middle of worst measles outbreak since 1991, with more than 5,400 cases nationally The United States could lose its measles elimination status this week, an event likely to cement health secretary Robert F. Kennedy Jr’s legacy of meddling in vaccine policies amid the worst outbreak of the virus in the US in 35 years. If the US loses its measles-free status, it would join Canada and several European and Asian nations that had eliminated the disease only for…

Read at The Guardian US

NPR The Associated Press

Ebola tops 11,000 cases in Congo's deadliest outbreak

Congo's Ebola outbreak has topped 11,000 cases, the government said Wednesday, a stark figure that underscores the severity of the situation as the country grapples with the relentless spread of the disease.

Read at NPR

arXiv (research papers) S M Rayeed SI

CLADE: Category-Level Answering from Deficient Evidence in Retrieval-Augmented Language Models

Retrieval-augmented systems often retrieve passages that are accurate and relevant but state the answer at a coarser level of granularity than the question requires. For example, a question may ask which specific disease a drug treats (familial hyperlipidemia), while the retrieved passage mentions the broader disease family (hyperlipidemia). Prior work on context sufficiency treats such coarse passages simply as insufficient. We argue that they form a distinct case, which we…

Read at arXiv (research papers)

GEN (Genetic Engineering & Biotechnology News) Alex Philippidis

Argenx Expands Immunology Capabilities with Up-to-$1.15B UNP Acquisition

The deal is designed to marry UNP’s macrocyclic peptide discovery platform with Argenx’s immunology innovation capabilities to broaden the buyer’s ability to develop oral or long-acting treatments for serious immune-mediated diseases.

Read at GEN (Genetic Engineering & Biotechnology News)

South China Morning Post Agence France-Presse Geopolitics

Over 3,000 already dead from cholera this year, says WHO

Cholera has killed more than 3,000 people worldwide since the start of the year, the World Health Organization said on Tuesday, insisting its goal of cutting global cases by 90 percent by 2030 remained in reach. The disease killed nearly 7,900 people in 2025, making it “the deadliest year for cholera since 1999”, according to Lorenzo Pezzoli, WHO lead for epidemic-prone bacterial diseases. While data for the first nine months of 2026 show a decline in deaths, more than 3,000…

Read at South China Morning Post

Al-Monitor

UNICEF says Israel blocks Gaza basin repairs, warns of flood risk

By Emma Farge GENEVA, Nov 10 (Reuters) - The UN children's agency said Israel had rejected the importation of equipment needed to repair a water basin in Gaza, and warned that the facility could overflow and endanger nearby residents through flooding and disease. Local authorities say Israel destroyed water infrastructure and vehicles used to pump water during itswar against Hamas, which had displaced most of the territory's more than 2 million ‌residents and ⁠left much of…

Read at Al-Monitor

Inc42 Anne Florentyna Startups

Froncort.AI Raises $2.3 Mn From Google.org To Expand AI-Based Disease Surveillance

Healthcare AI startup Froncort.AI has secured $2.3 Mn (₹21.5 Cr) in fresh capital from Google’s philanthropic arm, Google.org, to scale…

Read at Inc42

Analytics India Magazine Ridhika Basnet SI

Froncort.AI Gets $2.3M From Google.org to Expand AI-Based Disease Screening in India

Froncort.AI has received funding from Google.org to enhance its AI disease screening platform in India, aiding health workers in identifying risk areas.

Read at Analytics India Magazine

VnExpress International

Vietnamese hospital receives Japanese cell therapy technology for cancer and chronic disease treatment

Tam Anh General Hospital has completed an exclusive technology transfer from Japan's Grandsoul Medical Group covering immune cell and stem cell technologies being explored for treatment of cancer and chronic diseases.

Read at VnExpress International

Inquirer Global Nation dlejano Geopolitics

Ebola: Why is there still no vaccine?

1976: A hitherto unknown disease breaks out near the Ebola river in the country then known as Zaire, now the Democratic Republic of Congo (DRC). This was the first scientifically documented Ebola epidemic. Now, 50 years on, the DRC once…

Read at Inquirer Global Nation

Farm Progress

Is better biosecurity on your farm’s list for 2027?

Livestock Insights: From making designated entrances to isolating cattle, small changes in daily routines can help prevent disease from entering your operation.

Read at Farm Progress

Tech in Asia Minh Le Startups

Google.org grants $2.3m for Indian AI disease-screening app

Froncort.AI is one of 15 recipients of Google.org’s Impact Challenge: AI for Government Innovation.

Read at Tech in Asia

GEN (Genetic Engineering & Biotechnology News) Savannah Wiegel

Illumina Offers Early Access to Duplex Sequencing for MRD, Tumor Evolution Research

Illumina has announced an early access program to a duplex sequencing workflow that reads both DNA strands to detect trace ctDNA in molecular residual disease and tumor evolution studies. Kits are expected in early 2027.

Read at GEN (Genetic Engineering & Biotechnology News)

BioPharma Dive Delilah Alvarado

Vir hepatitis D drug succeeds in first pivotal study

A program that’s survived Vir’s pivot away from infectious disease research hit all of its study objectives and appeared more potent than a rival drug also in late-stage development.

Read at BioPharma Dive

BioPharma Dive Jacob Bell

Argenx to buy peptide platform in potentially billion-dollar deal

For $550 million up front, Argenx will take control of Unnatural Products’ “macrocyclic peptide” technology and direct it to develop oral, durable medicines for serious immune-mediated diseases.

Read at BioPharma Dive

ScienceDaily: Agriculture and Food

Scientists discover a surprising link between acorns and lyme disease

After more than 35 years of research, scientists have uncovered surprising clues about what really drives Lyme disease risk. Contrary to longstanding assumptions, deer populations appear less important than mice, which can fuel a 40% increase in tick numbers the following year. Even acorn production can predict tick population surges two years in advance, while extreme temperatures may be far less deadly to ticks than scientists once believed.

Read at ScienceDaily: Agriculture and Food

Tech.eu Tamara Djurickovic Startups

Vale Biolabs receives €164K from Venture Kick to advance brain disease research

Biotech startup Vale Biolabs has received€164,000 (CHF 150,000) from Venture Kick to advance its platform for studyingbrain diseases and evaluating potential treatments.Founded by Ilaria Incaviglia, A...

Read at Tech.eu

Frontiers in Sustainable Food Systems Jean Paul Ndayizeye

Access, not ability: gender disparities in access to smartphone-based AI advisory tools for banana disease management among smallholder farmers in Rwanda

Artificial intelligence (AI)-powered decision support tools can strengthen crop disease management, but their benefits reach farmers only when access is equitable. This study investigated how gender shapes access to smartphone-based AI advisory tools for banana disease management among smallholder farmers in Rwanda, using Tumaini, an AI-powered banana disease detection app, as a case. Using a mixed-method design, we combined a survey of 357 smallholder farmers across three…

Read at Frontiers in Sustainable Food Systems

Journal articles (OpenAlex) Thomas E. Ichim, Neil H Riordan · Journal of Translational Medicine

Immunological aspects of mesenchymal stem cell therapy for ALS

Neuroinflammation contributes to ALS progression, yet effective immune-modulating therapies remain limited. Despite the enthusiasm regarding stem cell therapy as a means of regeneration, it is interesting that the first FDA approval for mesenchymal stem cells (MSC) was for immune modulation, graft versus host disease (GVHD), not rejuvenation. We focus here on the immunological mechanisms through which MSC, particularly via induction of regulatory T cells, may slow…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Muthamizhan M., Sathyasri B. · Tehnicki vjesnik - Technical Gazette

IoT-Enabled Intelligent Diagnostic Framework Using Deep Learning and Multi-Feature Fusion Optimization

Accurate and early identification of diseases remains a major challenge in modern healthcare, where diagnostic delays can lead to critical outcomes. The shortage of medical specialists and the growing demand for rapid and reliable diagnosis highlight the need for intelligent and automated decision-support frameworks. This paper introduces a novel Medical Intelligence for Accurate Disease Detection using Deep Learning and Feature Fusion Strategies (MIADD-DLFFS) model designed…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Jean Paul Ndayizeye, Bonaventure Aman Omondi, Nozomi Kawarazuka et al. · Frontiers in Sustainable Food Systems Gadgets

Access, not ability: gender disparities in access to smartphone-based AI advisory tools for banana disease management among smallholder farmers in Rwanda

Artificial intelligence (AI)-powered decision support tools can strengthen crop disease management, but their benefits reach farmers only when access is equitable. This study investigated how gender shapes access to smartphone-based AI advisory tools for banana disease management among smallholder farmers in Rwanda, using Tumaini, an AI-powered banana disease detection app, as a case. Using a mixed-method design, we combined a survey of 357 smallholder farmers across three…

Read at Journal articles (OpenAlex)

STAT Biotech Elizabeth Cooney and Matthew Herper

STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy

Medical mystery at the AHA conference: A Novartis drug lowered a risk marker for cardiovascular disease but did not lower chance of heart attack or stroke.

Read at STAT Biotech

STAT Biotech Elizabeth Cooney

STAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatories

“These results, the fact that they're negative, does not invalidate that inflammation plays a very important role in cardiovascular disease."

Read at STAT Biotech

Journal articles (OpenAlex) Tian Gao, Lei He, Yuan Wang et al. · Plants

Biosynthetic Gene Clusters of Astragalus Triterpenoid Saponins: From Genome Discovery to Synthetic Biology and Biomanufacturing Prospects

Astragaloside IV is the best-characterized cycloartane-type triterpenoid saponin and the pharmacopoeial quality marker of Astragali Radix, with documented cardioprotective, antitumor, and immunomodulatory effects. Supply is constrained by long cultivation cycles that vary with production practice, replant disease, and phytochemical variability. Six representative genome assemblies are summarized for the genus, and they show that triterpenoid tailoring genes are partly, but…

Read at Journal articles (OpenAlex)

Hasht-e Subh (8am) Mohammad Farhaad

Low Awareness, Late Diagnosis Plague Osteoporosis Patients in Afghanistan

Osteoporosis is among the diseases that gradually reduce the density and strength of the bones and can limit people’s ability to carry out daily activities. Several doctors in Kabul say that the disease usually shows no specific symptoms in its early stages and may go undiagnosed until a fracture occurs. According to them, calcium and

Read at Hasht-e Subh (8am)

Hasht-e Subh (8am) Mohammad Farhaad

Cold Weather Brings Surge in Seasonal Illnesses as Kabul Residents Warn of Poor-Quality Medicines

A number of Kabul residents have expressed concern over the rise in seasonal illnesses. They say that with the drop in temperature and the increase in dust and air pollution, the risk of contracting various diseases, particularly respiratory diseases, has grown. The residents add that, on the one hand, the misdiagnosis of illnesses by some

Read at Hasht-e Subh (8am)

STAT Biotech Adam Feuerstein

STAT+: A closer look at ProMis Neurosciences and its Alzheimer’s drug

Shares of ProMis Neurosciences, developer of a treatment for Alzheimer’s disease, sold off sharply last week. A closer look at the reason why — and whether it holds up.

Read at STAT Biotech

STAT Biotech Jason Mast

STAT+: In China, a flood of controversial clinical trials slows to a trickle

Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US investors facing an uncertain future.

Read at STAT Biotech

Hasht-e Subh (8am) 8AM Media Geopolitics

Afghanistan Without Polio Urges Parents to Vaccinate Their Children

Afghanistan Without Polio has urged parents to vaccinate their children against polio to protect them from the disease. In a message on Thursday, November 5, the organization said the polio vaccination campaign was continuing that day to protect children against the disease. Afghanistan Without Polio also thanked parents for their cooperation in getting their children

Read at Hasht-e Subh (8am)

Journal articles (OpenAlex) Mehmet Oğuz Yardımcı, Ajay Kulkarni, Trey Ward et al. · Scientific Reports

AgriVision: adversarial image detection using Deep Learning in agricultural contexts

The digital transformation of agriculture has created cyber-physical systems in which biological processes are monitored and adjusted through sensory, digital, and visualpipelines. As these systems increasingly rely on artificial intelligence, controlled agriculture environments use biological inputs such as leaf images for disease detection and yield estimation; amongst other goals. Images used as input for on-the-farm decision making are frequently exposed to adversarial…

Read at Journal articles (OpenAlex)

Older stories